Intellectual Property
Patent Portfolio
SunInLyf Bio’s technology platforms are protected by issued and pending patents reflecting years of original research and development in the control, conversion, enhancement and delivery of light across optical systems, eyewear, displays, glass, medical devices and other advanced light-based applications. Our intellectual property extends beyond individual products to encompass core optical architectures, system integration, wavelength-conversion approaches, methods of use and a wide range of applications. Issued U.S. patents are supported by numerous pending U.S. and international applications designed to protect both today’s technologies and future commercial implementations. This expanding portfolio is intended to create multiple layers of protection around SunInLyf’s optical platforms while providing strategic partners with meaningful opportunities for differentiated products, protected market positions and long-term licensing value. Explore Our Patent Portfolio →
Patents
SunInLyf technologies, platforms, systems, devices, methods and applications may be protected by one or more issued U.S. patents and by additional pending U.S. and international patent applications. This webpage is intended to provide public notice of SunInLyf’s issued patent rights and, where applicable, to support virtual patent marking under 35 U.S.C. § 287(a). The patents and technologies identified on this page may not represent the full scope of SunInLyf’s intellectual property portfolio. Additional technologies, implementations, components, systems and applications may be covered by one or more issued or pending patents. The following issued patents protect core innovations underlying one or more SunInLyf technology platforms and form part of the broader intellectual property foundation supporting SunInLyf’s licensing, development and strategic partnership opportunities.
U.S. Patent No. 12,377,286
Technology Relevance
TheraVID™ — Displays, consumer electronics, wearable displays and related light-delivery systems.
Issued Claim Focus
Electronic display devices that integrate controlled photobiomodulation (PBM) light delivery with conventional video-display functionality. The issued claims include systems using dedicated or display-integrated light emitters, distance sensing, optical control, timing, cameras, user-responsive control and biofeedback to deliver selected PBM wavelengths while the device performs its conventional display functions.
U.S. Patent No. 12,654,028
Technology Relevance
TheraVID™ — Smart glasses, AR eyewear and next-generation wearable display systems.
Issued Claim Focus
Electronic eyewear and AR/display-equipped glasses that combine conventional visual-display functionality with controlled photobiomodulation (PBM) light delivery toward the wearer's eyes. The issued claims include configurations incorporating cameras, audio, display emitters, dedicated PBM emitters, optical elements, biological-data inputs and other smart-eyewear functionality.
Protection
Issued US patents provide strong legal protection for SunInLyf Bio's core optical innovations.
Licensing
Patent-protected platforms are available for strategic licensing across eyewear, display, and glass industries.
Development
SunInLyf Bio continues to develop and expand its IP portfolio as platforms advance toward commercialization.
Interested in Licensing?
SunInLyf Bio works with strategic partners to license and commercialize its patent-protected platforms. Contact us to explore licensing and development opportunities.